NCT05248906View on ClinicalTrials.gov

Giant Cell Arteritis - Optimization of Diagnostics

CompletedOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

March 19, 2021

Primary Completion Date

January 1, 2024

Study Completion Date

January 1, 2024

Conditions
Giant Cell Arteritis
Interventions
DIAGNOSTIC_TEST

Giant cell arteritis

Ultrasound 18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography Temporal artery biopsy

Trial Locations (1)

Unknown

Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT05248906 - Giant Cell Arteritis - Optimization of Diagnostics | Biotech Hunter | Biotech Hunter